Glioblastoma multiform prognosis beyond craniotomy and chemo irradiation


Author(s): Maithem Fadel Alashoor, Hisham Shaker Khsheesh Al-maliki, Khalid Faiq Abood Al-Khalidy and Ahmed Salih Alshewered*

Glioblastoma Multiform (GBM) is a malignant glioma with aggressive behavior and poor outcome. This study was done to assess the survival of GBM and to discover factors that can influence the survival. Retrospectively, from 2011 to 2021, a total of 50 individuals with histopathologically confirmed GBM and received adjuvant chemoradiation in Oncology Department were analyzed. The following data was collected: demographic profile (age and gender); Karnofsky Performance Status (KPS); gliomas site, surgery and treatment regimens. We could divided patients to two-groups according to age, fifty and below (19, 38%), and above fifty (31, 62%). Male to female ratio was 1.5:1. In relation to KPS, 30% were better score (≥90), 44% were have good score (70-80), and 26% were within poor score (<70). Parietal and temporal lobes were the most common parts involved by GBM. Most of patients underwent excisional biopsy in (38, 76%). All patients received the standard treatment included surgery and post-operative radiotherapy with or without concurrent and/or maintenance TMZ. The prognostic impact of various variables is described in table 2. In Logistic analysis, patients with age >50, and KPS<90 are worsen factors as compared to others. Otherwise, adjuvant therapy and lobe involvement were found to be independent prognostic factors GBM. In conclusion, older age and low performance status is a dependent prognostic factor for the clinical outcome of GBM. Multimodalities therapy may be not affected the prognosis or survival of GBM.

Share this article

Editors List


    Submitted PhD thesis in Biotechnology at GITAM University, Vizag.

  • Yousef Alomi

    Yousef Alomi
    The Past Head, General Administration of Pharmaceutical Care at Ministry of Health,
    Saudi Arabia Critical Care/TPN
    Clinical Pharmacist Ministry of Health,
    Riyadh, Saudi Arabia.

  • Osamu Tanaka

    Osamu Tanaka
    Assistant Professor,
    Department of Radiation Oncology
    Asahi University Hospital
    Gifu city, Gifu, Japan

  • Maher Abdel Fattah Al-Shayeb

    Department of Surgical Sciences, Ajman University, UAE

  • Andrzej Zdziennicki

    Institute of Gynecology and Obstetrics, Medical University of Lodz, I Clinic of Gynecology and Gynecological Oncology (Lodz, Poland)

Google Scholar citation report
Citations : 61

Onkologia i Radioterapia received 61 citations as per Google Scholar report

Onkologia i Radioterapia peer review process verified at publons
Indexed In
  • Scimago
  • MIAR
  • Euro Pub
  • Google Scholar
  • Medical Project Poland
  • Cancer Index
  • Gdansk University of Technology, Ministry Points 20